Rx Communications Group Expands Canadian Presence With Addition of Two New Clients

Rx Communications Group Expands Canadian Presence With Addition of Two New
Clients
DRAXIS Health, Inc. and Theratechnologies Inc. Retain Rx Communications As
Investor Relations Counsel 


NEW YORK, Feb. 23  /PRNewswire/ -- Rx Communications Group, LLC, a financial
communications firm specializing in the life science and healthcare industries,
today announced that the firm has been retained by DRAXIS Health Inc. (Nasdaq:
DRAX; TSX: DAX) and Theratechnologies Inc. (TSX: TH) for investor relations
counsel in the United States.  The addition of these accounts marks Rx'
expansion into the Canadian market, following the opening of the Company's
Toronto satellite office in September 2003.

Commenting on today's news, Rhonda Chiger, co-President of Rx Communications
Group, noted, "In building a presence in this market, our niche will be to work
closely with Canadian companies as they seek to increase their exposure to the
U.S. financial markets. Our goals on behalf of DRAXIS Health and
Theratechnologies, though tailored specifically to fit their needs, will focus
on improving the visibility, shareholder base and coverage of both firms among
key U.S. institutional investors and sell-side analysts, as well as within the
financial media community. We are delighted to be working with these companies
and look forward to long and lasting relationships with both."

Melody A. Carey, co-President of Rx Communications Group, said, "We have been
working diligently to expand our already well-regarded international client base
into the Canadian marketplace, and with the addition of DRAXIS Health and
Theratechnologies, we have made a strong start. Our Canadian outreach
initiatives have been in direct response to the growing interest among companies
there seeking to tap into the high level of specialization within the U.S.
markets. For Canadian companies dedicated to the life sciences, the U.S.
financial community offers a greater level of understanding and, potentially, a
greater valuation. We believe that our full service approach, coupled with our
RxIR USA(R) service -- for companies with minimum resources that wish to gain a
higher profile in the States -- will provide Canadian firms at all stages of
development with an ability to build a meaningful presence in the U.S. market."

DRAXIS Health Inc., located in Mississauga, Ontario, is a specialty
pharmaceutical company involved in the development, production, marketing and
distribution of therapeutic and diagnostic radiopharmaceuticals through
DRAXIMAGE Inc. and in the provision of pharmaceutical contract manufacturing
services, specializing in liquid and freeze-dried injectables and other sterile
products, through DRAXIS Pharma Inc.

Theratechnologies Inc., located in St. Laurent, Quebec, is a biotechnology
company engaged in the discovery and development of therapeutic products in the
field of endocrinology and metabolism. The company has and is developing a
portfolio of peptides at various stages of development for the treatment of
catabolic (lossof the body's synthesis and regeneration capacity) and metabolic
disorders, as well as osteoporosis and type II diabetes. In addition,
Theratechnologies is expanding its peptide portfolio through proven, proprietary
technologies. Its subsidiary, CelmedBioSciences, develops cell- based
therapies.

Rx Communications Group, LLC is a financial communications firm specializing in
the life science and healthcare industries. Rx provides investor relations,
media relations and corporate communications counsel to private and public
companies, worldwide. The firm designs, implements and manages full-service
programs, and handles transaction-oriented assignments. Rx executives are well
versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and
acquisitions. RxIR USA(R) is a service of Rx Communications geared toward
non-U.S. listed public foreign companies seeking to reach U.S. investors. For
more information about Rx Communications, visit the company's website at
http://www.rxir.com/. 

DATASOURCE: Rx Communications Group, LLC



CONTACT:  Pete Holmberg, Vice President Media Relations, Rx

Communications Group, LLC, [phone], 



Web site: http://www.rxir.com/ 

Copyright